Company profile: INCOG BioPharma Services
1.1 - Company Overview
Company description
- Provider of injectable drug product services, including formulation development, analytical method development, process scale up, and formulation/filling of vials, syringes, and cartridges for clinical and commercial manufacturing. Offers QC chemistry and microbiology testing, inspection, labeling, packaging, device assembly, and material/finished product storage.
Products and services
- Analytical Method and Process Development: Develops analytical methods and engineers processes to support production of injectable drug products, including process scale up for manufacturing readiness
- Scale-up-oriented
- Formulation & Filling Capabilities: Architects formulations and fills injectable drug products, handling multiple primary container presentations—vials, syringes, and cartridges—for both clinical and commercial manufacturing
- Clinical-to-commercial-scale
- Inspection Labeling and Packaging: Conducts inspection, applies labeling, and performs final packaging of injectable drug products to meet regulatory and market requirements
- Regulatory-compliant
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to INCOG BioPharma Services
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
CenExel
HQ: United States
Website
- Description: Provider of clinical research site network services supporting phase I-IV clinical trials, offering medical and scientific services to assist in the design and execution of clinical studies. Operates multiple centers across the country, delivering comprehensive resources to enhance research outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CenExel company profile →
Certis Oncology
HQ: United States
Website
- Description: Provider of precision oncology and translational science solutions, including Certis Oncology Intelligence® for predictive therapeutic response data from advanced cancer models with AI-driven bioinformatics; BarneyOI® cancer model database; CertisAI™ drug response prediction; O-PDX models; 3D cell cultures; and custom in vitro pharmacology and ex vivo assays, including cell line development, to help bridge the preclinical–clinical translation gap.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Certis Oncology company profile →
CSL
HQ: United States
Website
- Description: Provider of quality system, risk management, support, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSL company profile →
ProPharma
HQ: United States
Website
- Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for INCOG BioPharma Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to INCOG BioPharma Services
2.2 - Growth funds investing in similar companies to INCOG BioPharma Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for INCOG BioPharma Services
4.2 - Public trading comparable groups for INCOG BioPharma Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →